Challenges for Urologic Research: Moving Biomarkers into Practice


Statistical Considerations for Clinical Utility of a Bladder Cancer Biomarker

Sunday, May 20
10:35 AM - 10:55 AM
Location: MCC SOUTH, 208

Shahrokh Shariat

medical univ vienna

Dr. Shariat is currently professor and chairman of the department of urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria. He is also adjunct professor of urology and medical oncology at Weill Cornell Medical Center, New York, NY, adjunct professor of urology at the University of Texas Southwestern Medical Center, Dallas, TX, USA, and guest professor at the Faculty of Medicine, Charles University, Prague, CZ. He has published more than 900 peer-reviewed research papers (Scopus h-index 76, 23,553 citations; stand 12/2016), >200 non-peer-reviewed papers, and 18 book chapters. He is the holder of four patents stemming from his research into prostate and bladder cancer, and is the recipient of various national and international rewards. He is currently spearheading several collaborative multicenter groups (Bladder Cancer Research Consortium, The Bladder Cancer Detection Group, and The Upper Tract Urothelial Carcinoma Collaboration) and prospective clinical trials. He is a member of various academic societies and a journal, meeting abstract, and grant reviewer for numerous national and international organizations. He is an editorial board member of various journals including European Urology, BJU International, World Journal of Urology, Current Opinion in Urology (editor in chief), and Immunotherapy among others. His research focuses on urologic oncology - molecular mechanisms, markers, early detection, natural history, treatment, translational and outcomes research. Specially, Dr. Shariat's has been working on the discovery, testing, and validation of molecular markers associated with the biological and clinical behavior of prostate and urothelial cancers. His laboratory research focuses on integrative genomics and epigenomics of urothelial carcinoma with the goal of designing personalized therapeutic strategies.


Send Email for Shahrokh Shariat


Statistical Considerations for Clinical Utility of a Bladder Cancer Biomarker

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Statistical Considerations for Clinical Utility of a Bladder Cancer Biomarker